Evidence map›Paper›PMID 22495513›Full record

ArticleSocial science & medicine (1982)2012

HIV and chemoprophylaxis, the importance of considering social structures alongside biomedical and behavioral intervention.

Eric T Roberts, Derrick D Matthews

Abstract read
In one paragraph

Article in Social science & medicine (1982), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Retention of clients in HIV oral pre-exposure prophylaxis care in Engela, Namibia.African journal of primary health care & family medicine · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Expanding the knowledge translation metaphor.Health research policy and systems · 2017
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Microbicide clinical trial adherence: insights for introduction.Journal of the International AIDS Society · 2013
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Eric T RobertsColumbia University, Department of Epidemiology, Mailman School of Public Health, 710 W 168th Street, NI 614-A, New York, NY 10032, United States. etr2113@columbia.edu
Derrick D Matthews

Funding

BEHAVIORAL SCI TRAINING IN DRUG ABUSE RESEARCHT32DA007233 · NIDA · PUBLIC HEALTH SOLUTIONS · PI GOLDSAMT, LLOYD A · 1985 to 2023
$20.2M
NIDA NIH HHS 5T32 DA007233NIDA NIH HHS T32 DA007233
6 · The paper itself

Abstract

This manuscript draws connections between chemoprophylaxis and the biomedical model of disease that emphasizes individual behavior. We argue that chemoprophylactic HIV interventions have limited utility at the population-level, and that structural interventions need to be prioritized. We use the recent CAPRISA 004 and iPrEx trials to (a) critique the utility of these trials from a public health perspective by highlighting the difference between efficacy and effectiveness, (b) apply an alternative theory of health behavior as a way to reorient the field toward the discussion of the need to employ structural interventions, and (c) examine two aspects of HIV prevention efforts - funding structures and iatrogenic effects of biomedical approaches - as a means of overcoming obstacles to more widespread adoption of structural interventions.

Indexed as

Health BehaviorInterpersonal RelationsAntiviral AgentsChemopreventionFemaleHealth PromotionHIV InfectionsHumansMaleModels, BiologicalProgram EvaluationPsychological TheoryPublic Health PracticeRandomized Controlled Trials as TopicAntiviral Agents

Identifiers

PMID22495513
PMCPMC5849420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.